1 – 6 of 6
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
(
- Contribution to journal › Article
- 2016
-
Mark
MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC
(
- Contribution to journal › Article
- 2014
-
Mark
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
(
- Contribution to journal › Article
- 2013
-
Mark
Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC Therapies.
(
- Contribution to journal › Article
-
Mark
Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
(
- Contribution to journal › Article
- 2010
-
Mark
Human Embryonic Stem Cell Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune Modulatory Function Implications for off the Shelf ES MSC Therapies
(
- Contribution to journal › Published meeting abstract